About this FactMed analysis covering adverse side effect reports of AGGRENOX patients who developed DEPRESSION.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 118 individuals taking AGGRENOX reported DEPRESSION to the FDA. A total of 3940 AGGRENOX drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AGGRENOX and DEPRESSION. In doing so, we compare AGGRENOX with other drugs that cause DEPRESSION, to help you evaluate whether or not AGGRENOX causes DEPRESSION. Likewise, this page shows the most highly-reported side effects of AGGRENOX, so you can see if DEPRESSION ranks among AGGRENOX's most well-known side effects.
Summary Statistics
Reports of AGGRENOX causing DEPRESSION: 118
Reports of any side effect of AGGRENOX : 3940
Percentage of AGGRENOX patients where DEPRESSION is a reported side effect: 2.9949%

FDA reports of any drug causing DEPRESSION : 98155
Average percentage for all medicated patients where DEPRESSION is reported as a complication: 0.6152%

Physician opinion on AGGRENOX as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AGGRENOX:
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 573 patients )
TRANSIENT ISCHAEMIC ATTACK ( 426 patients )
CEREBROVASCULAR ACCIDENT ( 325 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 81 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 80 patients )
ANTICOAGULANT THERAPY ( 71 patients )
THROMBOSIS PROPHYLAXIS ( 25 patients )
ANTIPLATELET THERAPY ( 24 patients )
ISCHAEMIC STROKE ( 14 patients )
CAROTID ARTERY OCCLUSION ( 14 patients )
HYPERTENSION ( 12 patients )
ISCHAEMIC CEREBRAL INFARCTION ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CORONARY ARTERY DISEASE ( 9 patients )
CEREBRAL INFARCTION ( 7 patients )
VASCULAR SHUNT ( 7 patients )
ARTERIAL DISORDER ( 7 patients )
THROMBOSIS ( 7 patients )
LACUNAR INFARCTION ( 6 patients )
CARDIAC DISORDER ( 5 patients )
PLATELET AGGREGATION ABNORMAL ( 5 patients )
ANGIOPATHY ( 5 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 5 patients )
CEREBRAL ISCHAEMIA ( 5 patients )
CEREBROVASCULAR DISORDER ( 4 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
CEREBROVASCULAR INSUFFICIENCY ( 4 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 4 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
HYPERHOMOCYSTEINAEMIA ( 3 patients )
HYPOAESTHESIA FACIAL ( 3 patients )
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT ( 3 patients )
EPILEPSY ( 3 patients )
COAGULOPATHY ( 3 patients )
HEMIPARESIS ( 3 patients )
DIZZINESS ( 3 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 2 patients )
PHLEBITIS SUPERFICIAL ( 2 patients )
VARICOSE VEIN ( 2 patients )
CAROTID ARTERY DISEASE ( 2 patients )
MIGRAINE ( 2 patients )
CEREBRAL HAEMORRHAGE ( 2 patients )
BLOOD PRESSURE ( 2 patients )
SPEECH DISORDER ( 2 patients )
PAIN ( 2 patients )
CEREBRAL THROMBOSIS ( 2 patients )
PERIPHERAL ISCHAEMIA ( 2 patients )
ARTERY DISSECTION ( 2 patients )
VASCULAR CALCIFICATION ( 2 patients )
CONVULSION ( 2 patients )
ANGINA PECTORIS ( 2 patients )
CEREBELLAR INFARCTION ( 2 patients )
POST PROCEDURAL STROKE ( 2 patients )
HYPOAESTHESIA ( 2 patients )
BLOOD DISORDER ( 2 patients )
HYPOPERFUSION ( 2 patients )
OPTIC NERVE INFARCTION ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ENZYME ABNORMALITY ( 2 patients )
ESSENTIAL THROMBOCYTHAEMIA ( 1 patients )
ARTERIAL STENOSIS ( 1 patients )
THYROID STIMULATING IMMUNOGLOBULIN ( 1 patients )
FEELING ABNORMAL ( 1 patients )
ARTHRITIS ( 1 patients )
CEREBROVASCULAR STENOSIS ( 1 patients )
HAEMODILUTION ( 1 patients )
ATRIAL FLUTTER ( 1 patients )
CONCUSSION ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
VASCULAR DEMENTIA ( 1 patients )
AMNESIA ( 1 patients )
PLATELET COUNT ( 1 patients )
BALANCE DISORDER ( 1 patients )
VASCULITIS ( 1 patients )
CEREBRAL ARTERIOSCLEROSIS ( 1 patients )
BASAL GANGLION DEGENERATION ( 1 patients )
DIALYSIS ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
VERTIGO ( 1 patients )
OFF LABEL USE ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
HYPOTENSION ( 1 patients )
BRAIN STEM INFARCTION ( 1 patients )
EMBOLIC STROKE ( 1 patients )
ARRHYTHMIA ( 1 patients )
INFARCTION ( 1 patients )
THROMBOEMBOLIC STROKE ( 1 patients )
BRAIN STEM SYNDROME ( 1 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 1 patients )
ARTERIAL OCCLUSIVE DISEASE ( 1 patients )
ISCHAEMIA ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
EYE DISORDER ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
PLASMA VISCOSITY DECREASED ( 1 patients )
AMAUROSIS FUGAX ( 1 patients )
PLATELET AGGREGATION INHIBITION ( 1 patients )
ATRIAL SEPTAL DEFECT REPAIR ( 1 patients )
MICROANGIOPATHY ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
BASAL GANGLIA INFARCTION ( 1 patients )
DEEP VEIN THROMBOSIS ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
VASCULITIS CEREBRAL ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
NERVOUS SYSTEM DISORDER ( 1 patients )
VISUAL IMPAIRMENT ( 1 patients )
ANXIETY ( 1 patients )
CEREBRAL HYPOPERFUSION ( 1 patients )
RUPTURED CEREBRAL ANEURYSM ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
DYSARTHRIA ( 1 patients )
APHASIA ( 1 patients )
STENT PLACEMENT ( 1 patients )
BRAIN STEM ISCHAEMIA ( 1 patients )
PARAESTHESIA ( 1 patients )
INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DEPRESSION:

FOSAMAX (14302 patients)
VIOXX (14004 patients)
CHANTIX (12075 patients)
ACCUTANE (11815 patients)
SEROQUEL (6501 patients)
ASPIRIN (5780 patients)
ZOLOFT (4557 patients)
XANAX (4245 patients)
NEURONTIN (4113 patients)
AVONEX (3912 patients)
TRASYLOL (3803 patients)
LIPITOR (3699 patients)
PAXIL (3588 patients)
CYMBALTA (3414 patients)
LEXAPRO (3199 patients)
NEXIUM (3185 patients)
ZOMETA (3151 patients)
OXYCONTIN (3045 patients)
SYNTHROID (3026 patients)
AMBIEN (3003 patients)
CELEBREX (2979 patients)
LASIX (2957 patients)
PREDNISONE (2859 patients)
TYSABRI (2704 patients)
LISINOPRIL (2635 patients)
PROZAC (2565 patients)
PRILOSEC (2563 patients)
LYRICA (2563 patients)
EFFEXOR (2438 patients)
WELLBUTRIN (2274 patients)
KLONOPIN (2272 patients)
IBUPROFEN (2167 patients)
PREMARIN (2148 patients)
ALBUTEROL (2143 patients)
SINGULAIR (2115 patients)
LEVAQUIN (2109 patients)
YAZ (2093 patients)
ZOCOR (2068 patients)
VICODIN (2055 patients)
LORAZEPAM (2049 patients)
ATIVAN (2036 patients)
CLONAZEPAM (2016 patients)
ATENOLOL (1992 patients)
COUMADIN (1974 patients)
PREVACID (1962 patients)
AREDIA (1960 patients)
CELEXA (1928 patients)
DURAGESIC-100 (1892 patients)
HYDROCHLOROTHIAZIDE (1877 patients)
PROTONIX (1872 patients)
YASMIN (1852 patients)
EFFEXOR XR (1800 patients)
SIMVASTATIN (1794 patients)
PLAVIX (1748 patients)
REBIF (1642 patients)
NORVASC (1635 patients)
ZYPREXA (1609 patients)
ALPRAZOLAM (1604 patients)
PERCOCET (1603 patients)
FUROSEMIDE (1579 patients)
OMEPRAZOLE (1571 patients)
TOPROL-XL (1565 patients)
LEVOTHYROXINE SODIUM (1563 patients)
FOLIC ACID (1539 patients)
VALIUM (1499 patients)
GABAPENTIN (1470 patients)
ACETAMINOPHEN (1445 patients)
TRAZODONE HCL (1438 patients)
PEGASYS (1419 patients)
RIBAVIRIN (1380 patients)
DIAZEPAM (1376 patients)
LAMICTAL (1334 patients)
FLEXERIL (1330 patients)
HEPARIN (1320 patients)
LORTAB (1304 patients)
HUMIRA (1277 patients)
RISPERDAL (1273 patients)
[THERAPY UNSPECIFIED] (1263 patients)
ADVAIR DISKUS 100/50 (1245 patients)
BEXTRA (1243 patients)
NITROGLYCERIN (1239 patients)
METHOTREXATE (1232 patients)
TOPAMAX (1225 patients)
REMICADE (1213 patients)
FOSAMAX PLUS D (1173 patients)
DIGOXIN (1173 patients)
INSULIN (1167 patients)
POTASSIUM CHLORIDE (1150 patients)
VITAMIN D (1133 patients)
OXYCODONE HCL (1118 patients)
ZYRTEC (1117 patients)
PAROXETINE HCL (1087 patients)
CITALOPRAM HYDROBROMIDE (1085 patients)
AMOXICILLIN (1084 patients)
ALENDRONATE SODIUM (1066 patients)
ENBREL (1061 patients)
CRESTOR (1041 patients)
MIRAPEX (1026 patients)
DIOVAN (1020 patients)
MIRENA (1012 patients)
FENTANYL (1011 patients)
DEPAKOTE (1009 patients)
METFORMIN HCL (1000 patients)
AVANDIA (993 patients)
PEG-INTRON (991 patients)
ELAVIL (989 patients)
ALLEGRA (982 patients)
ZANTAC (981 patients)
FLUOXETINE (965 patients)
CALCIUM (957 patients)
TYLENOL (CAPLET) (930 patients)
MULTI-VITAMINS (922 patients)
ABILIFY (920 patients)
HYDROCODONE (919 patients)
MORPHINE (912 patients)
SEROQUEL XR (911 patients)
METOCLOPRAMIDE (909 patients)
PRISTIQ (900 patients)
BETASERON (896 patients)
GLUCOPHAGE (894 patients)
DEXAMETHASONE (893 patients)
ZITHROMAX (888 patients)
METOPROLOL TARTRATE (881 patients)
BACLOFEN (868 patients)
LOPRESSOR (863 patients)
MIRTAZAPINE (858 patients)
REGLAN (856 patients)
TYLENOL (855 patients)
HYDROCODONE BITARTRATE (855 patients)
CALCIUM (UNSPECIFIED) (854 patients)
ACTONEL (851 patients)
CLARITIN (840 patients)
ZOFRAN (835 patients)
ULTRAM (829 patients)
AMITRIPTYLINE HCL (824 patients)
PREMPRO (820 patients)
REMERON (815 patients)
LANTUS (814 patients)
CHAMPIX (810 patients)
FORTEO (807 patients)
PREDNISONE TAB (807 patients)
GEODON (804 patients)
VITAMIN E (803 patients)
ALLOPURINOL (801 patients)
NUVARING (800 patients)
COREG (797 patients)
TRAMADOL HCL (792 patients)
NAPROXEN (791 patients)
MOTRIN (761 patients)
SOMA (760 patients)
COPEGUS (754 patients)
BONIVA (740 patients)
BENADRYL (736 patients)
CIPROFLOXACIN (733 patients)
RANITIDINE (725 patients)
PEPCID (717 patients)
FLONASE (715 patients)
VITAMINS (UNSPECIFIED) (711 patients)
COZAAR (709 patients)
ACETYLSALICYLIC ACID SRT (707 patients)
TEGRETOL (704 patients)
PROMETHAZINE (702 patients)
SUBOXONE (702 patients)
METOPROLOL (702 patients)
CEPHALEXIN (699 patients)
CLONIDINE (699 patients)
ARIMIDEX (699 patients)
KEPPRA (697 patients)
TEMAZEPAM (697 patients)
ASCORBIC ACID (693 patients)
LITHIUM CARBONATE (689 patients)
ZETIA (688 patients)
SERTRALINE HYDROCHLORIDE (674 patients)
HEPARIN SODIUM INJECTION (668 patients)
MULTI-VITAMIN (667 patients)
OXYCODONE (652 patients)
DECADRON (651 patients)
RITALIN (649 patients)
WELLBUTRIN XL (648 patients)
VANCOMYCIN (647 patients)
TAMOXIFEN CITRATE (645 patients)
WARFARIN SODIUM (631 patients)
VITAMIN B-12 (627 patients)
SPIRONOLACTONE (627 patients)
COMPAZINE (624 patients)
LOVENOX (613 patients)
CLINDAMYCIN (604 patients)
SPIRIVA (603 patients)
ALTACE (602 patients)
METFORMIN (600 patients)
AMNESTEEM (599 patients)
FEMARA (594 patients)
DILAUDID (592 patients)
RESTORIL (591 patients)
COLACE (587 patients)
BUPROPION HCL (586 patients)
VERSED (582 patients)
ACTOS (581 patients)
TRILEPTAL (576 patients)
LEVOXYL (571 patients)
KEFLEX (568 patients)
VIAGRA (564 patients)
GLYBURIDE (561 patients)
ZESTRIL (558 patients)
REBETOL (557 patients)
PROVIGIL (556 patients)
MAGNEVIST (555 patients)
PROTAMINE SULFATE (552 patients)
DROSPIRENONE AND ETHINYL ESTRADIOL (551 patients)
ACIPHEX (550 patients)
Most common side effects for patients taking AGGRENOX:
HEADACHE (532 patients)
CEREBROVASCULAR ACCIDENT (466 patients)
NAUSEA (408 patients)
DIZZINESS (303 patients)
TRANSIENT ISCHAEMIC ATTACK (267 patients)
VOMITING (254 patients)
ASTHENIA (240 patients)
DIARRHOEA (234 patients)
FATIGUE (182 patients)
PAIN (176 patients)
FALL (170 patients)
PAIN IN EXTREMITY (149 patients)
DYSPNOEA (144 patients)
ANAEMIA (134 patients)
CHEST PAIN (130 patients)
RENAL FAILURE ACUTE (124 patients)
OEDEMA PERIPHERAL (122 patients)
ANXIETY (121 patients)
DEPRESSION (118 patients)
ABDOMINAL PAIN UPPER (113 patients)
HYPOAESTHESIA (112 patients)
HYPERTENSION (110 patients)
HYPOTENSION (105 patients)
MALAISE (104 patients)
CONFUSIONAL STATE (103 patients)
URINARY TRACT INFECTION (99 patients)
RENAL FAILURE (98 patients)
BACK PAIN (98 patients)
PNEUMONIA (96 patients)
WEIGHT DECREASED (95 patients)
ARTHRALGIA (94 patients)
GAIT DISTURBANCE (94 patients)
MYOCARDIAL INFARCTION (89 patients)
PYREXIA (89 patients)
DEHYDRATION (85 patients)
DRUG INEFFECTIVE (83 patients)
COUGH (83 patients)
MYALGIA (79 patients)
ATRIAL FIBRILLATION (79 patients)
CONVULSION (77 patients)
MUSCULAR WEAKNESS (77 patients)
DYSPHAGIA (76 patients)
LOSS OF CONSCIOUSNESS (76 patients)
PRURITUS (73 patients)
SOMNOLENCE (72 patients)
CONSTIPATION (72 patients)
CEREBRAL HAEMORRHAGE (72 patients)
FEELING ABNORMAL (72 patients)
INSOMNIA (71 patients)
ABDOMINAL PAIN (68 patients)
GASTROINTESTINAL HAEMORRHAGE (68 patients)
DECREASED APPETITE (67 patients)
RASH (67 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (66 patients)
HAEMORRHAGE (65 patients)
BLOOD PRESSURE INCREASED (65 patients)
DEATH (62 patients)
DYSPEPSIA (60 patients)
INJURY (59 patients)
BLOOD GLUCOSE INCREASED (59 patients)
SYNCOPE (59 patients)
ABDOMINAL DISCOMFORT (58 patients)
CEREBRAL INFARCTION (57 patients)
VISION BLURRED (57 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (57 patients)
HEMIPARESIS (56 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (56 patients)
RESPIRATORY FAILURE (55 patients)
MUSCLE SPASMS (54 patients)
CONTUSION (54 patients)
MEMORY IMPAIRMENT (54 patients)
NEUROPATHY PERIPHERAL (54 patients)
CARDIAC DISORDER (54 patients)
FLUSHING (53 patients)
HAEMOGLOBIN DECREASED (53 patients)
GASTRITIS (53 patients)
PARAESTHESIA (53 patients)
PALPITATIONS (52 patients)
SINUSITIS (50 patients)
RENAL FAILURE CHRONIC (50 patients)
DYSARTHRIA (50 patients)
EPISTAXIS (49 patients)
HYPERHIDROSIS (48 patients)
CARDIAC FAILURE CONGESTIVE (48 patients)
THROMBOCYTOPENIA (46 patients)
TREMOR (45 patients)
DYSGEUSIA (44 patients)
BALANCE DISORDER (44 patients)
CATARACT (43 patients)
SEPSIS (43 patients)
APHASIA (42 patients)
CORONARY ARTERY DISEASE (41 patients)
DEMENTIA (41 patients)
ABDOMINAL DISTENSION (40 patients)
SPEECH DISORDER (40 patients)
CONDITION AGGRAVATED (40 patients)
DIABETES MELLITUS (40 patients)
OFF LABEL USE (40 patients)
RETCHING (39 patients)
NECK PAIN (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
WEIGHT INCREASED (38 patients)
BLOOD CHOLESTEROL INCREASED (38 patients)
ARTERIOSCLEROSIS (38 patients)
OSTEONECROSIS OF JAW (38 patients)
ATELECTASIS (38 patients)
EMOTIONAL DISTRESS (37 patients)
DIVERTICULUM (37 patients)
DYSPNOEA EXERTIONAL (37 patients)
DUODENAL ULCER (37 patients)
RECTAL HAEMORRHAGE (36 patients)
OSTEOPENIA (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
RIB FRACTURE (36 patients)
CHEST DISCOMFORT (36 patients)
ANHEDONIA (35 patients)
URINARY INCONTINENCE (35 patients)
ABASIA (33 patients)
BLOOD CREATININE INCREASED (33 patients)
HYPERSENSITIVITY (33 patients)
ACUTE MYOCARDIAL INFARCTION (32 patients)
LUNG NEOPLASM MALIGNANT (32 patients)
VERTIGO (32 patients)
CARDIAC ARREST (32 patients)
HYPERLIPIDAEMIA (32 patients)
ERYTHEMA (31 patients)
MENTAL STATUS CHANGES (31 patients)
ISCHAEMIC STROKE (31 patients)
COLONIC POLYP (31 patients)
CAROTID ARTERY STENOSIS (31 patients)
TOOTHACHE (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
OVERDOSE (31 patients)
DYSPHONIA (31 patients)
TOOTH DISORDER (30 patients)
BLINDNESS (30 patients)
NIGHT SWEATS (30 patients)
AGEUSIA (29 patients)
LETHARGY (29 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (29 patients)
INFECTION (29 patients)
HAEMORRHOIDS (29 patients)
BRONCHITIS (29 patients)
URINARY RETENTION (29 patients)
DRY MOUTH (28 patients)
HAEMATURIA (28 patients)
HERPES ZOSTER (28 patients)
CYST (28 patients)
HYPOGLYCAEMIA (28 patients)
HALLUCINATION (28 patients)
HEAD INJURY (28 patients)
NEPHROLITHIASIS (28 patients)
RENAL CYST (28 patients)
EMPHYSEMA (27 patients)
HAEMATOMA (27 patients)
DISORIENTATION (27 patients)
THROMBOSIS (27 patients)
AMNESIA (27 patients)
FOOT FRACTURE (27 patients)
ANOREXIA (27 patients)
PLATELET COUNT DECREASED (27 patients)
INTERVERTEBRAL DISC DEGENERATION (27 patients)
GASTRITIS EROSIVE (27 patients)
CHILLS (27 patients)
ROTATOR CUFF SYNDROME (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
WHEEZING (26 patients)
HIP FRACTURE (26 patients)
DRUG INTERACTION (26 patients)
VISUAL IMPAIRMENT (26 patients)
FAECAL INCONTINENCE (25 patients)
SUBDURAL HAEMATOMA (25 patients)
CARDIOMEGALY (25 patients)
INCORRECT DOSE ADMINISTERED (25 patients)
CARDIO-RESPIRATORY ARREST (25 patients)
ORTHOSTATIC HYPOTENSION (25 patients)
CAROTID ARTERY OCCLUSION (25 patients)
BONE PAIN (25 patients)
MITRAL VALVE INCOMPETENCE (25 patients)
OSTEOARTHRITIS (25 patients)
HYPOKALAEMIA (25 patients)
HOT FLUSH (24 patients)
IRRITABLE BOWEL SYNDROME (24 patients)
PULMONARY FIBROSIS (24 patients)
SKIN TIGHTNESS (24 patients)
NOCTURIA (24 patients)
HYPERKALAEMIA (24 patients)
UNRESPONSIVE TO STIMULI (24 patients)
PLEURAL EFFUSION (24 patients)
OSTEOPOROSIS (24 patients)
HEART RATE INCREASED (24 patients)
JOINT SWELLING (24 patients)
TINNITUS (24 patients)
INFLUENZA LIKE ILLNESS (24 patients)
MIGRAINE (24 patients)
METABOLIC ACIDOSIS (23 patients)
RASH GENERALISED (23 patients)
ALANINE AMINOTRANSFERASE INCREASED (23 patients)
ALOPECIA (23 patients)
TACHYCARDIA (23 patients)
OESOPHAGITIS (23 patients)
INFLUENZA (23 patients)
HAEMATEMESIS (23 patients)
SPINAL OSTEOARTHRITIS (23 patients)
HYPERCALCAEMIA (23 patients)
COMA (23 patients)
CEREBRAL ATROPHY (23 patients)
SINUS BRADYCARDIA (23 patients)
AGITATION (22 patients)
TIBIA FRACTURE (22 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AGGRENOX


Issue Description / Topic Timestamp
QUESTION
NEUROPATHY
I am a 76 yr old female and take Aggrenox. Lately I have noticed numbness on the soles of both feet and above one knee to buttock and am trying to determine the cause. My doctor is guessing two pinched spinal nerves and has sent me to physical therapist. I've not noticed a change thus far and am trying to do my own sleuthing. Has anyone else had this reaction to the drug? 2014-11-21 20:22:34
QUESTION
MACULAR DEGENERATION
I've being taking aggrenox for a few years and although i'd recently was diagnosed with macular distrophy, i did not think aggrenox as a probable cause but on the other hand the Dr that diagnosed me told me that since there was no family history nor other facts like look at an eclipse directly etc he found no cause at so early age im 47, my question is, could be my problem a correlated cause of using this medicine, aggrenox? 2014-11-24 19:06:28
QUESTION
MACROGLOSSIA
I began taking Aggrenox Jan 2014. In approx June 2015 I was diagnosed with macroglossia - tongue swelling. Any chance it is caused by Aggrenox? I have been tested for allergies that was negative. Tongue is pushing on front teeth in sleep moving upper jaw significantly. Help! 2015-12-04 17:51:00
QUESTION
BURNING SENSATION
headackes and burning sensation over most of body. Can this be caused by taking Aggrenox? 2016-02-08 19:59:22
QUESTION
DRY MOUTH
Can aggrenox cause dry mouth? 2016-07-31 20:15:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DEPRESSION and AGGRENOX, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AGGRENOX, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AGGRENOX. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AGGRENOX experts. If you are a healthcare provider experienced in prescribing AGGRENOX, please register here.

Your online appointment book for Mentone Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use